Unichem Laboratories Limited (UNICHEMLAB.BO)
INR 587.6
(-2.16%)
INR 587.6
(-2.16%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 382.22 Million INR | -49.13% |
| 2022 | 751.42 Million INR | -27.46% |
| 2021 | 1.03 Billion INR | 623.83% |
| 2020 | 143.1 Million INR | -22.45% |
| 2019 | 184.53 Million INR | 0.0% |
| 2018 | - INR | -100.0% |
| 2017 | 3.26 Million INR | -25.34% |
| 2016 | 4.37 Million INR | -98.1% |
| 2015 | 229.8 Million INR | 13.35% |
| 2014 | 202.74 Million INR | -17.73% |
| 2013 | 246.45 Million INR | 17.97% |
| 2012 | 208.91 Million INR | -52.47% |
| 2011 | 439.56 Million INR | 5.34% |
| 2010 | 417.28 Million INR | 16.63% |
| 2009 | 357.77 Million INR | -9.95% |
| 2008 | 397.31 Million INR | 63.36% |
| 2007 | 243.21 Million INR | -7.66% |
| 2006 | 263.38 Million INR | -10.23% |
| 2005 | 293.4 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 606.74 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 382.22 Million INR | 0.0% |
| 2023 FY | 382.22 Million INR | -49.13% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q4 | 751.42 Million INR | 0.0% |
| 2022 FY | 751.42 Million INR | -27.46% |
| 2022 Q2 | 890.89 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q2 | 614.13 Million INR | 0.0% |
| 2021 FY | 1.03 Billion INR | 623.83% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.03 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 163.87 Million INR | 0.0% |
| 2020 FY | 143.1 Million INR | -22.45% |
| 2020 Q4 | 143.1 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q4 | 184.53 Million INR | 0.0% |
| 2019 FY | 184.53 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 192.89 Million INR | 0.0% |
| 2019 Q1 | - INR | 0.0% |
| 2018 FY | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | - INR | 0.0% |
| 2017 Q3 | 4.19 Million INR | 0.0% |
| 2017 FY | 3.26 Million INR | -25.34% |
| 2017 Q4 | 3.26 Million INR | -22.12% |
| 2016 Q4 | 4.37 Million INR | 0.0% |
| 2016 FY | 4.37 Million INR | -98.1% |
| 2015 FY | 229.8 Million INR | 13.35% |
| 2014 FY | 202.74 Million INR | -17.73% |
| 2013 FY | 246.45 Million INR | 17.97% |
| 2012 FY | 208.91 Million INR | -52.47% |
| 2011 FY | 439.56 Million INR | 5.34% |
| 2010 FY | 417.28 Million INR | 16.63% |
| 2009 FY | 357.77 Million INR | -9.95% |
| 2008 FY | 397.31 Million INR | 63.36% |
| 2007 FY | 243.21 Million INR | -7.66% |
| 2006 FY | 263.38 Million INR | -10.23% |
| 2005 FY | 293.4 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | 39.214% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 98.21% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -158.94% |
| Granules India Limited | 689.71 Million INR | 44.582% |
| Indoco Remedies Limited | 3.51 Billion INR | 89.133% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 235.2 Million INR | -62.509% |
| Alkem Laboratories Limited | 400 Million INR | 4.445% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -10621.487% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -1273.118% |
| Bajaj HealthCare Limited | 650.34 Million INR | 41.228% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -7.389% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 93.619% |
| Eris Lifesciences Limited | 6.54 Billion INR | 94.16% |
| FDC Limited | 2.46 Million INR | -15399.635% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 74.803% |
| Gufic Biosciences Limited | 1.53 Billion INR | 75.175% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -242.412% |
| Ipca Laboratories Limited | 5.8 Billion INR | 93.415% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -405.784% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 79.171% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Laurus Labs Limited | 8.6 Billion INR | 95.558% |
| Lupin Limited | 1.55 Billion INR | 75.385% |
| Mankind Pharma Limited | 248.67 Million INR | -53.702% |
| Medicamen Biotech Limited | 12.55 Million INR | -2944.373% |
| Medico Remedies Limited | 8.67 Million INR | -4307.53% |
| Megasoft Limited | 1.35 Billion INR | 71.835% |
| NATCO Pharma Limited | 53 Million INR | -621.172% |
| Piramal Pharma Limited | 24.83 Billion INR | 98.461% |
| RPG Life Sciences Limited | -30.3 Million INR | 1361.455% |
| Sigachi Industries Limited | 265.79 Million INR | -43.801% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -2773.842% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -79.991% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 31455.291% |
| Wanbury Limited | 820 Million INR | 53.388% |
| Windlas Biotech Limited | 20.18 Million INR | -1794.058% |
| ZIM Laboratories Limited | 356 Million INR | -7.364% |
| Zydus Lifesciences Limited | 251 Million INR | -52.279% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -258.556% |
| Divi's Laboratories Limited | 20 Million INR | -1811.105% |
| Hester Biosciences Limited | 1.81 Billion INR | 78.973% |
| Procter & Gamble Health Limited | 68.8 Million INR | -455.554% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -2636.405% |
| Bal Pharma Limited | 363.82 Million INR | -5.057% |
| Strides Pharma Science Limited | 6.71 Billion INR | 94.308% |
| Venus Remedies Limited | 386.8 Million INR | 1.184% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -95455.25% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 72.759% |
| Shilpa Medicare Limited | 5.6 Billion INR | 93.177% |
| Aarti Drugs Limited | 2.75 Billion INR | 86.118% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | 96.214% |
| Valiant Laboratories Limited | 746.63 Million INR | 48.807% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -61.684% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | 63.883% |
| Themis Medicare Limited | 267.74 Million INR | -42.758% |
| Hikal Limited | 4.22 Billion INR | 90.961% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 97.617% |
| Sequent Scientific Limited | 1.42 Billion INR | 73.219% |
| Novartis India Limited | 50.7 Million INR | -653.888% |
| Wockhardt Limited | 8.91 Billion INR | 95.71% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 98.793% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 449.2 Million INR | 14.912% |
| Morepen Laboratories Limited | 33.64 Million INR | -1036.21% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -186.22% |